The government's new medical cannabis guidelines have sparked concerns among patients and advocates, who warn that the changes could disrupt treatment and reduce effectiveness.

After the government recently announced new guidelines for medical cannabis, set to take effect on 1 January 2025, non-profit organisation Cannamedia has come forward to warn of the significant implications the revised position will have on patients in Luxembourg. According to spokesperson Line Olinger, alternatives will likely be less efficient due to different THC levels, with appropriate doses being extremely dependent on individual needs.

Olinger further contended that getting accustomed to new medication is a challenging process, which is why she believes the new regulations to be suboptimal and unfair to those who rely on the programme. She also expressed hopes that misconceptions among members of the health directorate will not lead to a complete abolishment of the programme.

In the new year, the use of THC-rich flowering tops will be discontinued while the maximum monthly prescription will be reduced to 60 grammes. At the time of the announcement, Health Minister Martine Deprez claimed that, to date, there are "no proven scientific conclusions" regarding "the widespread effectiveness or added value" of medicinal cannabis, with the government committed to reducing misuses as much as possible.

Video report in Luxembourgish